Alternative Splicing Factors and Cardiac Disease: More Than Just Missplicing?

Overview

Journal RNA

Specialty Molecular Biology

Date 2025 Jan 8

PMID 39773891

Authors

Zachery R Gregorich

Wei Guo

Affiliations

Soon will be listed here.

Abstract

Alternative splicing (AS) is the process wherein the exons from a single gene are joined in different combinations to produce nonidentical, albeit related, RNA transcripts. This process is important for the development and physiological function of many organs and is particularly important in the heart. Notably, AS has been implicated in cardiac disease and failure, and a growing number of genetic variants in AS factors have been identified in association with cardiac malformation and/or disease. With the field poised to interrogate how these variants affect cardiac development and disease, an understandable point of emphasis will undoubtedly be on downstream target gene missplicing. In this Perspective article, we would like to encourage consideration not only of the potential for novel disease mechanisms, but also for contributions from disruption of the ever-expanding list of nonsplicing functions ascribed to many AS factors. We discuss the emergence of a novel cardiac disease mechanism based on pathogenic RNA granules and speculate on the generality of such a mechanism among localization-disrupting AS factor genetic variants. We also highlight emerging nonsplicing functions attributed to several AS factors with cardiac disease-associated genetic variants in the hopes of pointing to avenues for exploration of mechanisms that may contribute to disease alongside target gene missplicing.

References

Verma S, Deshmukh V, Thatcher K, Belanger K, Rhyner A, Meng S . RBFOX2 is required for establishing RNA regulatory networks essential for heart development. Nucleic Acids Res. 2022; 50(4):2270-2286. PMC: 8881802. DOI: 10.1093/nar/gkac055. View

Kabashi E, Valdmanis P, Dion P, Spiegelman D, McConkey B, Vande Velde C . TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet. 2008; 40(5):572-4. DOI: 10.1038/ng.132. View

Cao J, Wei Z, Nie Y, Chen H . Therapeutic potential of alternative splicing in cardiovascular diseases. EBioMedicine. 2024; 101:104995. PMC: 10874720. DOI: 10.1016/j.ebiom.2024.104995. View

Glessner J, Bick A, Ito K, Homsy J, Rodriguez-Murillo L, Fromer M . Increased frequency of de novo copy number variants in congenital heart disease by integrative analysis of single nucleotide polymorphism array and exome sequence data. Circ Res. 2014; 115(10):884-896. PMC: 4209190. DOI: 10.1161/CIRCRESAHA.115.304458. View

Streckfuss-Bomeke K, Tiburcy M, Fomin A, Luo X, Li W, Fischer C . Severe DCM phenotype of patient harboring RBM20 mutation S635A can be modeled by patient-specific induced pluripotent stem cell-derived cardiomyocytes. J Mol Cell Cardiol. 2017; 113:9-21. DOI: 10.1016/j.yjmcc.2017.09.008. View

Boeckel J, Mobius-Winkler M, Muller M, Rebs S, Eger N, Schoppe L . SLM2 Is A Novel Cardiac Splicing Factor Involved in Heart Failure due to Dilated Cardiomyopathy. Genomics Proteomics Bioinformatics. 2021; 20(1):129-146. PMC: 9510876. DOI: 10.1016/j.gpb.2021.01.006. View

Linke W, Bucker S . King of hearts: a splicing factor rules cardiac proteins. Nat Med. 2012; 18(5):660-1. DOI: 10.1038/nm.2762. View

Vlasova I, Bohjanen P . Posttranscriptional regulation of gene networks by GU-rich elements and CELF proteins. RNA Biol. 2008; 5(4):201-7. PMC: 2642890. DOI: 10.4161/rna.7056. View

Beqqali A, Bollen I, Rasmussen T, van den Hoogenhof M, van Deutekom H, Schafer S . A mutation in the glutamate-rich region of RNA-binding motif protein 20 causes dilated cardiomyopathy through missplicing of titin and impaired Frank-Starling mechanism. Cardiovasc Res. 2016; 112(1):452-63. DOI: 10.1093/cvr/cvw192. View

10.

Song H, Hong S, Kim T, Kim D . Deep RNA sequencing reveals novel cardiac transcriptomic signatures for physiological and pathological hypertrophy. PLoS One. 2012; 7(4):e35552. PMC: 3327670. DOI: 10.1371/journal.pone.0035552. View

11.

Kong S, Hu Y, Ho J, Ikeda S, Polster S, John R . Heart failure-associated changes in RNA splicing of sarcomere genes. Circ Cardiovasc Genet. 2010; 3(2):138-46. PMC: 3073230. DOI: 10.1161/CIRCGENETICS.109.904698. View

12.

Nutter C, Jaworski E, Verma S, Deshmukh V, Wang Q, Botvinnik O . Dysregulation of RBFOX2 Is an Early Event in Cardiac Pathogenesis of Diabetes. Cell Rep. 2016; 15(10):2200-2213. PMC: 4899142. DOI: 10.1016/j.celrep.2016.05.002. View

13.

Methawasin M, Hutchinson K, Lee E, Smith 3rd J, Saripalli C, Hidalgo C . Experimentally increasing titin compliance in a novel mouse model attenuates the Frank-Starling mechanism but has a beneficial effect on diastole. Circulation. 2014; 129(19):1924-36. PMC: 4032222. DOI: 10.1161/CIRCULATIONAHA.113.005610. View

14.

Gordon J, Phizicky D, Neugebauer K . Nuclear mechanisms of gene expression control: pre-mRNA splicing as a life or death decision. Curr Opin Genet Dev. 2020; 67:67-76. PMC: 8084925. DOI: 10.1016/j.gde.2020.11.002. View

15.

Guo W, Zhu C, Yin Z, Wang Q, Sun M, Cao H . Splicing Factor RBM20 Regulates Transcriptional Network of Titin Associated and Calcium Handling Genes in The Heart. Int J Biol Sci. 2018; 14(4):369-380. PMC: 5930469. DOI: 10.7150/ijbs.24117. View

16.

Kornblihtt A, Schor I, Allo M, Dujardin G, Petrillo E, Munoz M . Alternative splicing: a pivotal step between eukaryotic transcription and translation. Nat Rev Mol Cell Biol. 2013; 14(3):153-65. DOI: 10.1038/nrm3525. View

17.

Pan Q, Shai O, Lee L, Frey B, Blencowe B . Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet. 2008; 40(12):1413-5. DOI: 10.1038/ng.259. View

18.

Yamamoto T, Miura A, Itoh K, Takeshima Y, Nishio H . RNA sequencing reveals abnormal LDB3 splicing in sudden cardiac death. Forensic Sci Int. 2019; 302:109906. DOI: 10.1016/j.forsciint.2019.109906. View

19.

Nishiyama T, Zhang Y, Cui M, Li H, Sanchez-Ortiz E, McAnally J . Precise genomic editing of pathogenic mutations in rescues dilated cardiomyopathy. Sci Transl Med. 2022; 14(672):eade1633. PMC: 10088465. DOI: 10.1126/scitranslmed.ade1633. View

20.

Wyles S, Li X, Hrstka S, Reyes S, Oommen S, Beraldi R . Modeling structural and functional deficiencies of RBM20 familial dilated cardiomyopathy using human induced pluripotent stem cells. Hum Mol Genet. 2015; 25(2):254-65. PMC: 4706113. DOI: 10.1093/hmg/ddv468. View